United Health Products, Inc. (OTCQB: UEEC.PK), which develops and markets products and technologies in the healthcare sector, today announced that its hemostatic gauze, which is registered and branded in the U.S.A. under the trademark HemoStyp™, has been granted use of CE mark which is a mandatory conformity mark for products placed on the market in the European Economic Area (EEA) http://www.efta.int/eea.aspx, under the application and registration of its manufacturing agent. UEEC’s CEO Philip Forman stated, “United Health Products is excited to announce that its product labeled under the HemoStyp™ brand is now being provided and manufactured with both CE and FDA marks. We now are exploring several potential opportunities for distribution of the HemoStyp™ gauze within the European Economic Area.” Douglas Beplate COO of Epic Wound Care Inc. acknowledged that a market test of the HemoStyp™ gauze is being negotiated with several European Companies.
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's operating subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudates/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.
Safe Harbor StatementSafe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV